<DOC>
<DOCNO>EP-0617028</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]
 piperazine
</INVENTION-TITLE>
<CLASSIFICATIONS>C07B5300	C07D29506	C07D29522	C07D295088	A61P3708	A61K31495	A61K31495	A61P2522	A61P4300	A61P4300	C07D29508	C07D29500	A61P2900	C07D295073	C07D29526	A61P1100	A61P2520	A61P3700	A61P2500	A61P1106	C07D29504	A61P2900	C07B5300	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07B	C07D	C07D	C07D	A61P	A61K	A61K	A61P	A61P	A61P	C07D	C07D	A61P	C07D	C07D	A61P	A61P	A61P	A61P	A61P	C07D	A61P	C07B	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07B53	C07D295	C07D295	C07D295	A61P37	A61K31	A61K31	A61P25	A61P43	A61P43	C07D295	C07D295	A61P29	C07D295	C07D295	A61P11	A61P25	A61P37	A61P25	A61P11	C07D295	A61P29	C07B53	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Laevorotatory and dextrorotatory enantiomers of 1-Ä(4-chlorophenyl)phenylmethylÜ-4-Ä(4-methylphenyl)sulphonylÜ-piperaz ine of formula 
<
IMAGE
>
 their preparation and their use in the preparation of the substantially optically pure enantiomers of 1-Ä(4-chlorophenyl)phenylmethylÜpiperazine which are themselves valuable intermediates in the preparation of optically active therapeutic compounds of very high optical purity.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
Laevorotatory and dextrorotatory enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]
piperazine of formula

Method for preparing the laevorotatory and
dextrorotatory enantiomers of 1-[(4-chlorophenyl)phenylmethyl]
-4-[(4-methylphenyl)sulfonyl]piperazine of formula I according to

claim 1, characterized in that an enantiomer of (4-chlorophenyl)phenylmethylamine
of formula



is reacted with an N,N-diethyl-4-methylbenzenesulfonamide
of formula


 
in which X represents a chlorine, bromine or iodine atom,

or the (4-methylphenyl)sulfonyloxy group or the
methylsulfonyloxy group, in the presence of 2.2 to 4.4

equivalents of an organic or inorganic base per equivalent
of the enantiomer of (4-chlorophenyl)phenylmethylamine and

at the boiling point of the reaction mixture.
Method according to claim 2, characterized in that the
base is chosen from the group consisting of

ethyldiisopropylamine, N-ethylmorpholine, 2,4,6-trimethylpyridine,
triethylamine and an alkali metal

carbonate.
Method according to either of claims 2 or 3,
characterized in that the base is ethyldiisopropylamine.
Use of the laevorotatory and dextrorotatory enantiomers
of 1-[(4-chlorophenyl)phenylmethyl]
-4-[(4-methylphenyl)sulfonyl]piperazine

of formula I according to
claim 1, for the preparation of the enantiomers of 1-[(4-chlorophenyl)phenylmethyl]
piperazine
of formula



by hydrolysis with hydrobromic acid, in an acetic acid
medium, in the presence of a phenolic compound, preferably

4-hydroxybenzoic acid.
Method for preparing the laevorotatory and
dextrorotatory enantiomers of 1-[(4-chlorophenyl)phenylmethyl]
piperazine
of formula 



characterized in that an enantiomer of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]
piperazine of formula


is hydrolysed with hydrobromic acid, in an acetic acid

medium, in the presence of a phenolic compound, preferably
4-hydroxybenzoic acid, at a temperature comprised between

18 and 100°C.
</CLAIMS>
</TEXT>
</DOC>
